Target
Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188]
Ligand
BDBM236464
Substrate
n/a
Meas. Tech.
Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay
Temperature
298.15±n/a K
IC50
0.134±n/a nM
Comments
extracted
Citation
 Cotesta, SFuret, PGuagnano, VHolzer, PKallen, JMah, RMasuya, KSchlapbach, AStutz, SVaupel, A Pyrrolopyrrolidinone compounds US Patent  US9365576 Publication Date 6/14/2016 
Target
Name:
Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188]
Synonyms:
p53-MDM2
Type:
Protein
Mol. Mass.:
n/a
Description:
n/a
Components:
This complex has 2 components.
Component 1
Name:
Cellular tumor antigen p53 [18-26]
Synonyms:
P53 | P53_HUMAN | TP53 | Tumor suppressor p53
Type:
Protein
Mol. Mass.:
1122.31
Organism:
Homo sapiens (Human)
Description:
aa 18-26
Residue:
9
Sequence:
TFSDLWKLL
  
Component 2
Name:
E3 ubiquitin-protein ligase Mdm2 [2-188]
Synonyms:
E3 ubiquitin-protein ligase Mdm2 | MDM2 | MDM2_HUMAN
Type:
Protein
Mol. Mass.:
21187.98
Organism:
Homo sapiens (Human)
Description:
aa 2-188
Residue:
187
Sequence:
CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS
  
Inhibitor
Name:
BDBM236464
Synonyms:
US9365576, 220
Type:
Small organic molecule
Emp. Form.:
C30H29Cl2N5O6
Mol. Mass.:
626.487
SMILES:
CCOC(=O)c1c2C(=O)N(C(c2n(C(C)C)c1-c1cnc(OC)nc1OC)c1ccc(Cl)cc1)c1cc(Cl)c(=O)n(C)c1 |(3.26,6.8,;2.17,5.71,;2.57,4.22,;1.48,3.13,;.39,4.22,;1.08,1.64,;-.38,1.17,;-1.85,1.64,;-2.62,2.98,;-2.75,.4,;-1.85,-.85,;-.38,-.37,;1.08,-.85,;1.48,-2.33,;.39,-3.42,;2.97,-2.73,;1.98,.4,;3.52,.4,;4.29,-.94,;5.83,-.94,;6.6,.4,;8.14,.4,;8.91,-.94,;5.83,1.73,;4.29,1.73,;3.52,3.07,;4.29,4.4,;-2.25,-2.33,;-3.74,-2.73,;-4.13,-4.22,;-3.05,-5.31,;-3.44,-6.8,;-1.56,-4.91,;-1.16,-3.42,;-4.29,.4,;-5.06,1.73,;-6.6,1.73,;-7.37,3.07,;-7.37,.4,;-8.91,.4,;-6.6,-.94,;-7.37,-2.27,;-5.06,-.94,)|
Structure:
Search PDB for entries with ligand similarity: